HEALTHPEAK PROPERTIES INC (DOC) Forecast, Price Target & Analyst Ratings

NYSE:DOC • US42250P1030

Current stock price

16.14 USD
+0.15 (+0.94%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for HEALTHPEAK PROPERTIES INC (DOC).

Forecast Snapshot

Consensus Price Target

Price Target
$19.59
+ 21.38% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Jul 22, 2026
Period
Q1 / 2026
EPS Estimate
$0.05
Revenue Estimate
701.51M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
73.91%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$19.59
Upside
+ 21.38%
From current price of $16.14 to mean target of $19.59, Based on 23 analyst forecasts
Low
$16.16
Median
$19.38
High
$30.45

Price Target Revisions

1 Month
-0.48%
3 Months
-2.13%

Price Target Summary

23 Wall Street analysts provided a forecast for the next 12 months for DOC. The average price target is 19.59 USD. This implies a price increase of 21.38% is expected in the next year compared to the current price of 16.14.
The average price target has been revised downward by 2.13% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

DOC Current Analyst RatingDOC Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10

Analyst Ratings History

DOC Historical Analyst RatingsDOC Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20

Analyst Ratings Consensus

ChartMill Buy Consensus
73.91%
DOC was analyzed by 23 analysts. The buy percentage consensus is at 74. So analysts seem to be have mildly positive about DOC.
In the previous month the buy percentage consensus was at a similar level.
DOC was analyzed by 23 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-04-28Morgan StanleyMaintains Overweight -> Overweight
2026-04-20UBSInitiate Neutral
2026-04-06BairdMaintains Outperform -> Outperform
2026-04-01CitigroupMaintains Neutral -> Neutral
2026-02-05Argus ResearchDowngrade Buy -> Hold
2026-02-04Evercore ISI GroupMaintains Outperform -> Outperform
2026-02-02Wells FargoMaintains Equal-Weight -> Equal-Weight
2026-01-09Goldman SachsInitiate Neutral
2025-12-16JefferiesDowngrade Buy -> Hold
2025-12-15Evercore ISI GroupMaintains Outperform -> Outperform
2025-11-25Wells FargoMaintains Equal-Weight -> Equal-Weight
2025-11-12BairdMaintains Outperform -> Outperform
2025-10-01Cantor FitzgeraldInitiate Neutral
2025-09-15Raymond JamesUpgrade Market Perform -> Outperform
2025-08-27Wells FargoMaintains Equal-Weight -> Equal-Weight
2025-08-22Morgan StanleyMaintains Overweight -> Overweight
2025-08-20Deutsche BankDowngrade Buy -> Hold
2025-07-30BairdMaintains Outperform -> Outperform
2025-07-29ScotiaBankDowngrade Sector Outperform -> Sector Perform
2025-06-02Wells FargoMaintains Equal-Weight -> Equal-Weight
2025-05-12ScotiaBankMaintains Sector Outperform -> Sector Outperform
2025-04-29Argus ResearchReiterate Buy -> Buy
2025-04-29BairdMaintains Outperform -> Outperform
2025-04-28WedbushMaintains Outperform -> Outperform
2025-04-28Evercore ISI GroupMaintains Outperform -> Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
Jul 22, 2026
Period
Q1 / 2026
EPS Estimate
$0.05
Revenue Estimate
701.51M
Revenue Q2Q
-0.20%
EPS Q2Q
-15.83%
Number of Analysts
8

Next Earnings Revisions

Revenue (1 Month)
1.30%
Revenue (3 Months)
0.82%
EPS (1 Month)
-8.33%
EPS (3 Months)
-12.00%

Next Earnings Summary

DOC is expected to report earnings on 7/22/2026. The consensus EPS estimate for the next earnings is 0.05 USD and the consensus revenue estimate is 701.51M USD.
The next earnings revenue estimate has been revised upward by 0.82% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
DOC revenue by date.DOC revenue by date.
2.181B
5.81%		2.7B
23.82%		2.823B
4.52%		2.877B
1.93%		3.035B
5.49%		3.17B
4.45%		3.467B
9.37%		3.66B
5.57%		3.847B
5.11%		4.03B
4.76%		4.216B
4.62%
EBITDA
YoY % growth
DOC ebitda by date.DOC ebitda by date.
1.189B
7.66%		1.519B
27.67%		1.604B
5.62%		1.591B
-0.80%		1.659B
4.27%		1.817B
9.52%		1.959B
7.82%		2.066B
5.46%		2.17B
5.03%		2.272B
4.70%		2.376B
4.58%
EBIT
YoY % growth
DOC ebit by date.DOC ebit by date.
439.511M
11.49%		461.361M
4.97%		545.025M
18.13%		505.17M
-7.31%		552.29M
9.33%		572.18M
3.60%		637.47M
11.41%		687.68M
7.88%		731.41M
6.36%		771.44M
5.47%		814.93M
5.64%
Operating Margin
DOC operating margin by date.DOC operating margin by date.
20.15%17.08%19.31%17.56%18.20%18.05%18.39%18.79%19.01%19.14%19.33%
EPS
YoY % growth
DOC eps by date.DOC eps by date.
0.56
-38.86%		0.35
-37.50%		0.350.22
-37.96%		0.25
13.18%		0.26
4.80%		0.30
17.65%		0.36
20.00%		0.41
13.89%		0.46
12.20%		0.52
10.87%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		0.05
-15.83%		0.06
11.10%		0.05
-32.67%		0.06
-60.02%		0.08
60.00%		0.08
45.45%		0.08
50.01%		0.07
10.53%
Revenue
Q2Q % growth		701.51M
-0.20%		709.57M
2.19%		713.65M
1.10%		726.33M
0.96%		748.11M
6.64%		760.98M
7.25%		771.03M
8.04%		764.07M
5.20%
EBITDA
Q2Q % growth		393.08M
-3.47%		397.05M
-40.06%		394.1M
-57.56%		397.41M
-67.03%		409.92M
4.28%		413.3M
4.09%		415.94M
5.54%		440.87M
10.94%
EBIT
Q2Q % growth		129.82M
-6.36%		132.86M
3.81%		151.73M
15.14%		165.91M
13.16%		148.07M
14.06%		152.31M
14.64%		155.44M
2.45%		N/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

DOC Yearly Revenue VS EstimatesDOC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1B 2B 3B 4B
DOC Yearly EPS VS EstimatesDOC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0.5 1 1.5 2

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-9.72%
EPS Next 5 Year
0.77%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
4.42%
Revenue Next 5 Year
5.62%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
59.69%
EBIT Next 5 Year
35.87%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

HEALTHPEAK PROPERTIES INC / DOC Forecast FAQ

Can you provide the average price target for HEALTHPEAK PROPERTIES INC stock?

23 analysts have analysed DOC and the average price target is 19.59 USD. This implies a price increase of 21.38% is expected in the next year compared to the current price of 16.14.

What is the next earnings date for DOC stock?

HEALTHPEAK PROPERTIES INC (DOC) will report earnings on 2026-07-22.

What are the consensus estimates for HEALTHPEAK PROPERTIES INC (DOC) next earnings?

The consensus EPS estimate for the next earnings of HEALTHPEAK PROPERTIES INC (DOC) is 0.05 USD and the consensus revenue estimate is 701.51M USD.

Can you provide the consensus rating for HEALTHPEAK PROPERTIES INC stock?

The consensus rating for HEALTHPEAK PROPERTIES INC (DOC) is 73.913 / 100 . This indicates that analysts generally have a positive outlook on the stock.